alemtuzumab (campath) Report issue

Biologics mAb Orphan Drug FDA Approved FDA Accelerated Approval FDA
AACT ChEMBL DrugBank Drug Central Drugs@FDA KEGG MeSH repoDB
Back

Drug Pricing Summary

AUS PBS

$8392.0798

VA Big4

$16714.3200

VA FSS

$21094.6300

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
alemtuzumab 12 mg / 1.2 mL (1.2 mL INJECTION) $8392.0798 AUS PBS generic
  • Lemtrada (1)
    		•  sanofi-aventis Australia Pty Ltd
    alemtuzumab 12 mg / 1.2 mL (1.2 mL INJECTION) $16714.3200 VA Big4
  • LEMTRADA (1)
    		•  Genzyme Corporation dba Genzyme Therapeutics Division
    alemtuzumab 12 mg / 1.2 mL (1.2 mL INJECTION) $21094.6300 VA FSS
  • LEMTRADA (1)
    		•  Genzyme Corporation dba Genzyme Therapeutics Division

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue